The PM Society, which supports companies and individuals working in pharma marketing and healthcare communications, has created a new Industry Council and expanded its Board of Directors.
Once widely acknowledged as so special that only scientists and clinical specialists need to apply, oncology has become exponentially more clinically targeted and sophisticated over the las
As the digital era of communication continues to expand and flourish, the way life sciences companies interact with their customer is evolving rapidly.
Endeavor BioMedicines has completed a third round financing, raising an impressive $132.5 million to fund trials of its two clinical-stage drug candidates for pulmonary fi
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.